All posts

Take a pass on Descartes Systems, says Industrial Alliance

Ahead of Descartes Systems Group’s (TSX:DSG Quote, Chart, NASDAQ:DSGX) quarterly financial report, Industrial Alliance Securities analyst Blair Abernethy maintains his “Hold” rating for the logistics management company with an unchanged target price of $28.00.

SaaS company Descartes Systems will announce its fiscal 2019 second quarter ended July 31 financials on September 5, with consensus expectations for $67.5 million in revenue, representing an 18.1 per cent year over year increase, and EBITDA of $23.1 million, representing a 34 EBITDA margin, with an EPS of $0.26. (All figures in US dollars.)

Abernethy expects Descartes’ organic revenue growth to remain in the mid-single digit range over the near term, with both recent and future acquisitions to be a factor going forward.

“Trading at 29.1x P/E (F2019E), we are watching for potential catalysts, including accretive acquisitions, large retail customer wins, and improved organic revenue growth driven by cross selling (particularly in the trade content businesses),” says Abernethy in a client update on Wednesday.

“Since July 2015, Descartes has made 12 acquisitions for a total value of ~$377 million. The company has a cash balance of $36 million, available bank lines of $99 million, and a $750 million shelf prospectus, providing it with ample capacity, in our opinion, to continue to be a consolidator in its market over the next few years,” he says.

In terms of valuation, Abernethy says that DSGX is trading at 29.1x P/E on his fiscal 2019 estimate. “We note that comparable supply chain technology companies are trading at EV/Sales of 6-7x, while pure SaaS providers are trading at an EV/Sales range of 7-8x,” he says. “Descartes is trading at EV/Sales of 9.4x on F2019E, which is at the upper end of SaaS vendors.”

At the time of publication, Abernethy’s target represents a projected 12-month return of negative 15.4 per cent.

Tagged with: dsg
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Verano Holdings is undervalued, Haywood says

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings (Verano Holdings Stock Quote, Chart, News, Analysts, Financials NEO:VRNO) is staying… [Read More]

3 days ago

Knight Therapeutics is a buy, Stifel says

Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSXV:GUD) is continuing to build momentum, according to Stifel Nicolaus… [Read More]

3 days ago

Groupon wins price target raise at Roth

Roth Capital Partners has raised its price target on Groupon (Groupon Inc Stock Quote, Chart, News, Analysts, Financials NASDAQ:GRPN) to… [Read More]

3 days ago

Trulieve Cannabis is a buy, Beacon says

Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL) delivered a strong start to fiscal 2025, beating high-end… [Read More]

3 days ago

Green Thumb Industries should be a core holding for cannabis investors, analyst says

Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News, Analysts, Financials CSE:GTII) delivered a steady first quarter and remains… [Read More]

3 days ago

5N Plus just delivered an “exceptional” quarter, this analyst says

5N Plus (5N Plus Stock Quote, Chart, News, Analysts, Financials TSX:VNP) blew past expectations in the first quarter of 2025,… [Read More]

4 days ago